Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction

EMBO J. 2000 Aug 15;19(16):4257-64. doi: 10.1093/emboj/19.16.4257.

Abstract

The reverse tetracycline-dependent transactivator system was employed in insulinoma INS-1 cells to achieve controlled inducible expression of hepatocyte nuclear factor-1 alpha (HNF1 alpha)-P291fsinsC, the most common mutation associated with subtype 3 of maturity-onset diabetes of the young (MODY3). Nuclear localized HNF1 alpha-P291fsinsC protein exerts its dominant-negative effects by competing with endogenous HNF1 alpha for the cognate DNA-binding site. HNF1 alpha controls multiple genes implicated in pancreatic beta-cell function and notably in metabolism- secretion coupling. In addition to reduced expression of the genes encoding insulin, glucose transporter-2, L-pyruvate kinase, aldolase B and 3-hydroxy-3-methylglutaryl coenzyme A reductase, induction of HNF1 alpha-P291fsinsC also significantly inhibits expression of mitochondrial 2-oxoglutarate dehydrogenase (OGDH) E1 subunit mRNA and protein. OGDH enzyme activity and [(14)C]pyruvate oxidation were also reduced. In contrast, the mRNA and protein levels of mitochondrial uncoupling protein-2 were dramatically increased by HNF1 alpha-P291fsinsC induction. As predicted from this altered gene expression profile, HNF1 alpha-P291fsinsC also inhibits insulin secretory responses to glucose and leucine, correlated with impaired nutrient-evoked mitochondrial ATP production and mitochondrial membrane hyperpolarization. These unprecedented results suggest the molecular mechanism of HNF1 alpha-P291fsinsC causing beta-cell dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / biosynthesis
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Binding Sites
  • Blotting, Northern
  • Blotting, Western
  • Cell Line
  • Cell Nucleus / metabolism
  • DNA / metabolism
  • DNA-Binding Proteins*
  • Diabetes Mellitus, Type 2 / genetics
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Doxycycline / pharmacology
  • Fructose-Bisphosphate Aldolase / metabolism
  • Genes, Dominant
  • Glucose Transporter Type 2
  • Hepatocyte Nuclear Factor 1
  • Hepatocyte Nuclear Factor 1-alpha
  • Hepatocyte Nuclear Factor 1-beta
  • Humans
  • Hydroxymethylglutaryl CoA Reductases / metabolism
  • Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent
  • Immunoblotting
  • Insulin / metabolism
  • Ion Channels
  • Islets of Langerhans / metabolism
  • Islets of Langerhans / physiology*
  • Ketoglutarate Dehydrogenase Complex / metabolism
  • Membrane Potentials
  • Membrane Transport Proteins*
  • Microscopy, Fluorescence
  • Mitochondria / enzymology
  • Mitochondrial Proteins*
  • Monosaccharide Transport Proteins / metabolism
  • Mutation*
  • Nuclear Proteins*
  • Oxygen / metabolism
  • Phosphorylation
  • Promoter Regions, Genetic
  • Proteins / metabolism
  • Pyruvate Kinase / metabolism
  • Pyruvates / metabolism
  • Rats
  • Temperature
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transcription Factors / physiology*
  • Transfection
  • Uncoupling Protein 2
  • Up-Regulation

Substances

  • Anti-Bacterial Agents
  • DNA-Binding Proteins
  • Glucose Transporter Type 2
  • HNF1A protein, human
  • HNF1B protein, human
  • Hepatocyte Nuclear Factor 1-alpha
  • Hnf1a protein, rat
  • Insulin
  • Ion Channels
  • Membrane Transport Proteins
  • Mitochondrial Proteins
  • Monosaccharide Transport Proteins
  • Nuclear Proteins
  • Proteins
  • Pyruvates
  • Transcription Factors
  • UCP2 protein, human
  • Ucp2 protein, rat
  • Uncoupling Protein 2
  • Hepatocyte Nuclear Factor 1
  • Hepatocyte Nuclear Factor 1-beta
  • Adenosine Triphosphate
  • DNA
  • Hydroxymethylglutaryl CoA Reductases
  • Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent
  • Ketoglutarate Dehydrogenase Complex
  • Pyruvate Kinase
  • Fructose-Bisphosphate Aldolase
  • Doxycycline
  • Oxygen